Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nifedipine sustained release tablets and preparation process thereof

A preparation process, a technology for nifedipine, which is applied in the directions of pill delivery, cardiovascular system diseases, pharmaceutical formulations, etc., can solve the problems of short duration of action, accompanied by adverse reactions, complicated preparation process, etc., and achieves a slow dissolution rate, convenient for The effect of mass production and simple production process

Active Publication Date: 2013-10-23
浙江泰利森药业有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the existing nifedipine sustained-release tablets still have unsatisfactory parts such as short duration of action (generally 12 hours, taking 2 times a day), often accompanied by adverse reactions; Dipine controlled-release tablets, although their drug release stability is better than sustained-release tablets, and only need to be taken once a day, all need to adopt laser pore-forming osmotic pump type controlled release technology, which has complicated preparation process, high manufacturing cost, and high yield. Insufficient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nifedipine sustained release tablets and preparation process thereof
  • Nifedipine sustained release tablets and preparation process thereof
  • Nifedipine sustained release tablets and preparation process thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] The nifedipine sustained-release tablet of the present invention is prepared from the following raw materials and auxiliary materials in the weight ratio:

[0018] Nifedipine 20%

[0019] Chitosan 14%

[0020] Dextrin 60%

[0021] Ethylcellulose 4%

[0022] Sodium Lauryl Sulfate 1%

[0023] Magnesium Stearate 1%

[0024] Wherein nifedipine is used as raw material, chitosan is used as sustained-release agent, dextrin is used as filler, ethyl cellulose is used as binder, sodium lauryl sulfate is used as solubilizer, and magnesium stearate is used as lubricant.

[0025] Preparation process: crush nifedipine and pass through a 200-mesh stainless steel sieve; mix nifedipine, chitosan, sodium lauryl sulfate and dextrin according to weight percentage; Add 80% ethanol to the cellulose to make soft material from ethyl cellulose with a weight concentration of 8%—80% ethanol solution; pass the soft material through a 20-mesh stainless steel sieve to make wet granules; put the...

Embodiment 2

[0027] The nifedipine sustained-release tablet of the present invention is prepared from the following raw materials and auxiliary materials in the weight ratio:

[0028] Nifedipine 20%

[0029] Chitosan 17%

[0030] Dextrin 57%

[0031] Ethylcellulose 4%

[0032] Sodium Lauryl Sulfate 1%

[0033] Magnesium Stearate 1%

[0034] Among them, nifedipine is used as raw material, chitosan is used as slow-release agent, dextrin is used as filler, ethyl cellulose is used as binder, sodium lauryl sulfate is used as solubilizer, and magnesium stearate is used as lubricant.

[0035] Preparation process: crush nifedipine and pass through a 200-mesh stainless steel sieve; mix nifedipine, chitosan, sodium lauryl sulfate and dextrin according to weight percentage; add ethyl cellulose after the raw and auxiliary materials are evenly mixed - 80% ethanol solution to make soft material; pass the soft material through a 20-mesh stainless steel sieve to make wet granules; dry the wet granule...

Embodiment 3

[0037]The nifedipine sustained-release tablet of the present invention is prepared from the following raw materials and auxiliary materials in the weight ratio:

[0038] Nifedipine 20%

[0039] Chitosan 20%

[0040] Dextrin 54%

[0041] Ethylcellulose 4%

[0042] Sodium Lauryl Sulfate 1%

[0043] Magnesium Stearate 1%

[0044] Wherein nifedipine is used as raw material, chitosan is used as sustained-release agent, dextrin is used as filler, ethyl cellulose is used as binder, sodium lauryl sulfate is used as solubilizer, and magnesium stearate is used as lubricant.

[0045] Preparation process: crush nifedipine and pass through a 200-mesh stainless steel sieve; mix nifedipine, chitosan, sodium lauryl sulfate and dextrin according to weight percentage; add ethyl cellulose after the raw and auxiliary materials are evenly mixed - 80% ethanol solution to make soft materials; pass the soft materials through a 20-mesh stainless steel sieve to make wet granules; dry the wet granu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses nifedipine sustained release tablets and a preparation process thereof. The nifedipine sustained release tablets are prepared from nifedipine, a sustained release agent, a bulking agent, a bonding agent, a solubilizer and a lubricant by the steps of pulverizing, sieving, mixing, granulating, drying, tabletting and film coating. The sustained release agent adopts chitosan, and weight percentages of the components are as follows: nifedipine 20%, chitosan 14-24%, bulking agent 50-60%, bonding agent 4%, solubilizer 1%, and lubricant 1%. The nifedipine sustained release tablets of the invention are simple in production process and long in sustained release action, the adverse reactions after administration are less and mild, and the curative effect on mild and moderate hypertension is definite. The nifedipine sustained release tablets can uniformly release nifedipine within 24 hours, can last the effective blood concentration over 24 hours, and only need to be administered once everyday.

Description

technical field [0001] The invention relates to the field of drug sustained-release preparations, in particular to a nifedipine sustained-release tablet and a preparation process thereof. Background technique [0002] Nifedipine is one of the calcium antagonists. It is a blood pressure lowering drug. It has a strong effect of dilating coronary arteries and peripheral arteries, and has a significant effect of inhibiting vasospasm. Due to the short half-life of nifedipine ordinary tablets (about 2.0 hours) and short maintenance time, patients need to take the medicine multiple times (3 to 4 times a day) to achieve the purpose of lowering blood pressure. Because the release rate of common nifedipine preparations is not stable, the blood drug concentration in the human body fluctuates greatly, and side effects such as dizziness, flushing and heart palpitations are likely to occur. The human body releases it slowly and evenly at a certain speed, so that the drug effect is mo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/22A61K9/28A61K31/4422A61K47/36A61K47/38A61P9/12
Inventor 肖亚宝崔生法文君韩风
Owner 浙江泰利森药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products